mk0557
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Sep 1, 2002 (NCT00533598)
Timeline
Indications
Mechanism of action
- Neuropeptide Y receptor type 1INHIBITOR
NPY1R inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk0557
- mk0557
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00482430 | Phase 2 | Sep 1, 2007 | Merck |
| NCT00533481 | Phase 2 | Feb 1, 2004 | Merck |
| NCT00092872 | Phase 3 | Nov 1, 2003 | Merck |
| NCT00092859 | Phase 3 | Aug 1, 2003 | Merck |
| NCT00533598 | Phase 2 | Sep 1, 2002 | Merck |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 5 | 5 | 2 | 2002 |
1 organizations
Page 1 / 1